Supplementary Figure 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas

Abstract

Supplementary Figure 2 shows changes in NGFR and CD274 (PD-L1) gene and protein expression in human lung cancer tumoroids in response to EZH2 inhibitor and interferon-gamma treatment.</p